Skip to main content
. 2017 Apr 27;12(4):e0176075. doi: 10.1371/journal.pone.0176075

Fig 1. 3D co registered PET/CT imaging of MIA-PaCA-2 and CHL-1 xenograft tumor bearing mice at 144 hours post tracer (0.5 mg/kg of 89Zr-GSK2849330) injection.

Fig 1

The images show high uptake in the CHL-1 tumor (mid-panel) compared to the MIA-PaCa-2 tumor (left-panel). However the uptake was higher in the CHL-1 group (right-panel) which received a non-labeled dose (50 mg/kg) of GSK2849330 16 hours prior to the tracer dose.